Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot

March 11, 2026 updated by: Rita Bakhru, Medical University of South Carolina

Integration of a Behavioral Health Collaborative Care Model Into an ICU Recovery Clinic-Pilot for Families

This pilot study evaluates the feasibility and acceptability of implementing a Behavioral Health Collaborative Care Model (BH CoCM) for family members of ICU survivors. The intervention includes telehealth-enabled behavioral health assessments and access to the NeuroFlow platform. A subset of participants will undergo qualitative interviews.

Study Overview

Detailed Description

Patients seen in the MUSC ICU Recovery Clinic will be approached for consent for care through our Behavioral Health Collaborative Care Model. Patients and their families that consent will be randomized to an attention control group or an intervention group.

The intervention group will have access to NeuroFlow platform, which has been specifically designed to support delivery of a BH CoCM. They will utilize Neuroflow for 6 months. They will undergo assessments for anxiety, depression, post-traumatic stress The attention control group will undergo assessments for anxiety, depression, post-traumatic stress.

Investigators will look at changes over six months in intervention group compared to attention control group for patients in terms of symptoms of depression, anxiety, post-traumatic stress. Investigators will also look at adherence, BH CoCM implementation metrics, type and amount of guided content accessed in NeuroFlow. Investigators will perform qualitative surveys to understand better what patients thought about the intervention and ways in which it could be improved.

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29407
        • Recruiting
        • Medical University of South Carolina
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- Family member of ICU Recovery Clinic patient enrolled in parent BH CoCM study

Exclusion Criteria:

  • Serious mental illness (e.g., schizophrenia, mania)
  • Late-stage dementia or cognitive impairment
  • Limited English proficiency
  • No internet-enabled device
  • Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional
behavioral health collaborative care model in ICU recovery patients and families
No Intervention: Control
Attention Control.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Consent Rate
Time Frame: Baseline
Investigators will assess the consent rate
Baseline
Study Completion Rate
Time Frame: enrollment to 6 months
We will assess the completion rate of all enrolled family members
enrollment to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Monthly Completion Rate of PHQ9 (Patient Health Questionnaire 9)
Time Frame: Enrollment to 6 months
Rate of completion of scheduled monthly assessment: PHQ9
Enrollment to 6 months
Monthly Completion Rate of GAD 7 (General Anxiety Disorder 7)
Time Frame: baseline to 6 months
Rate of completion of scheduled monthly assessment: GAD7
baseline to 6 months
Monthly Completion Rate of PCL 5 (PTSD Checklist for DSM-5)
Time Frame: baseline to 6 months
Rate of Completion of scheduled monthly assessment: PCL5
baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rita Bakhru, MD, Medical University of South Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

June 30, 2028

Study Registration Dates

First Submitted

January 12, 2026

First Submitted That Met QC Criteria

January 28, 2026

First Posted (Actual)

February 5, 2026

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 11, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

De-identified data may be used for future research without additional consent.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on Behavioral Treatment

Subscribe